Area of research
Epidemiology · Neurology
Research interest
Research interests include Acute Ischemic Stroke Management, Intracerebral and Subarachnoid Hemorrhage Research, Cerebrovascular and Carotid Artery Diseases, and Stroke Rehabilitation and Recovery.
Safety and efficacy of transcranial direct current stimulation in addition to constraint-induced movement therapy for post-stroke motor recovery (TRANSPORT2): a phase 2, multicentre, randomised, sham-controlled triple-blind trial
Volume Tolerance and Prognostic Impact of Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage
Apixaban to Prevent Covert Infarcts After Cryptogenic Stroke in Patients With Atrial Cardiopathy
Should We Stop Endovascular Treatment of M2 Occlusions?: A Critical Look at Recent Evidence
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke
Atrial cardiopathy biomarkers and atrial fibrillation in the ARCADIA trial
Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence
Improving Stroke Risk Factor Management Focusing on Health Disparities and Knowledge Gaps
A Phase III, prospective, double-blind, randomized, placebo-controlled trial of thrombolysis in imaging-eligible, late-window patients to assess the efficacy and safety of tenecteplase (TIMELESS): Rationale and design
Abstract TP213: Arcadia CSI (Cognition And Silent Infarcts): Update
Acute Stroke Imaging Research Roadmap IV: Imaging Selection and Outcomes in Acute Stroke Clinical Trials and Practice
The Utility of Domain-Specific End Points in Acute Stroke Trials
What is the median volume of intracerebral hemorrhage and is it changing?
Thrombolysis in Mild Stroke
Thrombectomy for Stroke in the Public Health Care System of Brazil
Temporal Trends in Stroke Incidence Over Time by Sex and Age in the GCNKSS
National Institutes of Health StrokeNet During the Time of COVID-19 and Beyond
Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial
Original and Modified Graeb Score Correlation With Intraventricular Hemorrhage and Clinical Outcome Prediction in Hyperacute Intracranial Hemorrhage
Efficacy of Home-Based Telerehabilitation vs In-Clinic Therapy for Adults After Stroke
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
Detailed phenotyping of posterior vs. anterior circulation ischemic stroke: a multi-center MRI study
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods
Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design